VM26 therapy in children with drug-refractory lymphocytic leukemia.
D002648:Child; D003561:Cytarabine / Q000627:therapeutic use*; D004341:Drug Evaluation; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D011241:Prednisone / Q000627:therapeutic use; D013713:Teniposide / Q000627:therapeutic use*; D014750:Vincristine / Q000627:therapeutic use
D003561:Cytarabine; D014750:Vincristine; D013713:Teniposide; D011034:Podophyllotoxin; D011241:Prednisone